In a research report issued this morning, Brean Capital analyst Difei Yang maintained a Buy rating on shares of Zogenix, Inc. (NASDAQ:ZGNX) and raised the price …
Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders, announced the appointments of Gail …
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) has increased $5.78 in mid-day trading to $8.
Brean Capital analyst Difei Yang weighed in today with his prediction Zogenix, Inc. (NASDAQ:ZGNX) ahead of the reverse stock split that will be implemented on …
Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders, announced that at the annual …
Brean Capital analyst Difei Yang weighed in with some insights on Zogenix, Inc. (NASDAQ:ZGNX) ahead of the vote to approve a reverse stock split of outstanding …
In a research report released Thursday, Brean Capital analyst Difei Yang maintained a Buy rating on Zogenix, Inc. (NASDAQ:ZGNX) with a price target of …
Brean Capital’s healthcare analyst Difei Yang weighed in with her views on Zogenix, Inc. (NASDAQ:ZGNX), after the company released its first-quarter results, posting revenue of …
Oppenheimer’s healthcare analyst Akiva Felt reiterated an Outperform rating on Zogenix, Inc. (NASDAQ:ZGNX) with a $2.
Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders, provided a corporate update, and …
